Class information for:
Level 1: MTIC//DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL//VLAK PROTOCOL

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
19491 438 25.2 65%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
2084 4777 O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE//ALKYLTRANSFERASE//O 6 BENZYLGUANINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MTIC Author keyword 11 100% 1% 6
2 DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL Address 8 23% 7% 29
3 VLAK PROTOCOL Author keyword 6 100% 1% 4
4 SEZ CHIM FARMACEUT BIOL Address 4 40% 2% 8
5 1 2 3 5 TETRAZEPINONES Author keyword 3 100% 1% 3
6 ANNELATED PYRROLO PYRIMIDINES Author keyword 3 100% 1% 3
7 DEVELOPMENTAL THERAPEUTICS PROGRAM DTP Author keyword 3 100% 1% 3
8 DIAZOINDOLES Author keyword 3 100% 1% 3
9 IMIDAZOTETRAZINES Author keyword 3 100% 1% 3
10 TETRAZEPINONES Author keyword 3 100% 1% 3

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 MTIC 11 100% 1% 6 Search MTIC Search MTIC
2 VLAK PROTOCOL 6 100% 1% 4 Search VLAK+PROTOCOL Search VLAK+PROTOCOL
3 1 2 3 5 TETRAZEPINONES 3 100% 1% 3 Search 1+2+3+5+TETRAZEPINONES Search 1+2+3+5+TETRAZEPINONES
4 ANNELATED PYRROLO PYRIMIDINES 3 100% 1% 3 Search ANNELATED+PYRROLO+PYRIMIDINES Search ANNELATED+PYRROLO+PYRIMIDINES
5 DEVELOPMENTAL THERAPEUTICS PROGRAM DTP 3 100% 1% 3 Search DEVELOPMENTAL+THERAPEUTICS+PROGRAM+DTP Search DEVELOPMENTAL+THERAPEUTICS+PROGRAM+DTP
6 DIAZOINDOLES 3 100% 1% 3 Search DIAZOINDOLES Search DIAZOINDOLES
7 IMIDAZOTETRAZINES 3 100% 1% 3 Search IMIDAZOTETRAZINES Search IMIDAZOTETRAZINES
8 TETRAZEPINONES 3 100% 1% 3 Search TETRAZEPINONES Search TETRAZEPINONES
9 5 AMINOIMIDAZOLE 4 CARBOXAMIDE 2 67% 0% 2 Search 5+AMINOIMIDAZOLE+4+CARBOXAMIDE Search 5+AMINOIMIDAZOLE+4+CARBOXAMIDE
10 TREATMENT INDUCED 2 67% 0% 2 Search TREATMENT+INDUCED Search TREATMENT+INDUCED

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 IMIDAZOTETRAZINES 61 88% 7% 29
2 MITOZOLOMIDE 49 78% 7% 32
3 ANTITUMOR IMIDAZOTETRAZINES 37 40% 16% 72
4 DRUG TEMOZOLOMIDE 30 100% 3% 12
5 ANTITUMOR DRUG TEMOZOLOMIDE 27 76% 4% 19
6 POLYCONDENSED NITROGEN HETEROCYCLES 19 76% 3% 13
7 3 TRIAZENOPYRROLES 17 100% 2% 8
8 NSC 362856 17 75% 3% 12
9 ANTITUMOR AGENT TEMOZOLOMIDE 15 82% 2% 9
10 VLAK PROTOCOL 12 86% 1% 6

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Temozolomide and treatment of malignant glioma 2000 239 94 44%
Temozolomide: A review of its discovery, chemical properties, pre-clinical development and clinical trials 1997 382 78 46%
Role of temozolomide in pediatric brain tumors 2006 21 31 48%
Temozolomide in the treatment of solid tumours: current results and rationale for dosing/scheduling 2005 33 57 35%
The Use of Temozolomide for the Treatment of Malignant Tumors: Clinical Evidence and Molecular Mechanisms of Action 2010 15 128 23%
Current and future developments in the use of temozolomide for the treatment of brain tumours 2001 101 52 33%
Temozolomide with Radiation Therapy in High Grade Brain Gliomas: Pharmaceuticals Considerations and Efficacy; A Review Article 2009 10 51 35%
Recent Approaches to Improve the Antitumor Efficacy of Temozolomide 2009 30 128 16%
Temozolomide in patients with high grade gliomas 2000 14 27 52%
Temozolomide: a milestone in neuro-oncology and beyond? 2006 30 122 17%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 DIPARTIMENTO FARMACOCHIM TOSSICOL BIOL 8 23% 6.6% 29
2 SEZ CHIM FARMACEUT BIOL 4 40% 1.8% 8
3 IST FARMACOCHIM 2 26% 1.4% 6
4 ANN ARBOR HEMATOL ONCOL ASSOCIATES 1 50% 0.2% 1
5 CANC DRUG MED ONCOL 1 50% 0.2% 1
6 DIPARTIMENTO SCI PEDIAT MEDICOCHIRURG NEUROSCI 1 50% 0.2% 1
7 HOSKINS BIOMED 1 50% 0.2% 1
8 ALBERTA HOSP 0 33% 0.2% 1
9 CANC UNITED KINGDOM POSITRON EMISS TOMOG ONCO 0 33% 0.2% 1
10 HIGH POTENT ACT PHARMACEUT INGREDIENTS OPERAT 0 33% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000190259 BIS TRIAZENE//TRIAZENE//BISTRIAZENE
2 0.0000168851 O 6 ALKYLGUANINE DNA ALKYLTRANSFERASE//O 6 BENZYLGUANINE//ALKYLTRANSFERASE
3 0.0000133202 TEMOZOLOMIDE//GLIOBLASTOMA MULTIFORME//ANAPLASTIC ASTROCYTOMA
4 0.0000128402 EGFRVIII//RECURRENT GLIOBLASTOMA//TUMOR TREATING FIELDS
5 0.0000092332 CONJUGATED AZOMETHINE YLIDE//AZEPINES//CINCIAS QUIM
6 0.0000082157 GOLD PROMOTION//KYRTUTHRIX MACULANS//2 3 DIHYDROFURAN
7 0.0000069480 BIOCHEMOTHERAPY//METASTATIC MELANOMA//DACARBAZINE
8 0.0000062010 PANICLE EXSERTION//ADDITIVE METHODS//EDUC FIELD SCI
9 0.0000056916 NITROBUTADIENES//NITROTHIOPHENES//1 4 BIS1 NAPHTHYL 2 3 DINITRO 1 3 BUTADIENE
10 0.0000054754 IDH1//IDH2//ISOCITRATE DEHYDROGENASE 1